54 phenotypes from 11 alleles in 12 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Plec/Parp10tm1.1Gwi/Plec/Parp10tm1.1Gwi involves: BALB/cJ * C57BL/6	abnormal axon morphology	J:155511
	normal behavior/neurological phenotype	J:155511
	decreased nerve conduction velocity	J:155511
Plecem1(IMPC)Bay/Plecem1(IMPC)Bay C57BL/6N-Plecem1(IMPC)Bay/BayMmucd	edema	J:211773
	preweaning lethality, complete penetrance	J:211773
PlecGt(U3Betageo)1Ruiz/PlecGt(U3Betageo)1Ruiz involves: 129S2/SvPas * C57BL/6	prenatal lethality, complete penetrance	J:85162
Plectm1Gwi/Plectm1Gwi involves: 129S1/Sv * 129X1/SvJ	abnormal dermal layer morphology	J:59000
	abnormal epidermis stratum basale morphology	J:59000
	abnormal intercalated disk morphology	J:59000
	abnormal keratinocyte morphology	J:59000
	abnormal myocardial fiber morphology	J:59000
	abnormal skeletal muscle fiber morphology	J:59000
	absent epidermis stratum basale	J:59000
	blistering	J:59000
	decreased body weight	J:59000
	hemorrhage	J:59000
	muscle degeneration	J:59000
	myopathy	J:59000
	postnatal lethality, complete penetrance	J:59000
	skin detachment	J:59000
Plectm1Gwi/Plectm4Gwi Tg(Ckmm-cre)5Khn/? involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB	abnormal heart morphology	J:137067
	abnormal muscle fiber mitochondrial morphology	J:137067
	abnormal myocardial fiber morphology	J:137067
	abnormal sarcolemma morphology	J:137067
	abnormal skeletal muscle fiber morphology	J:137067
	abnormal soleus morphology	J:137067
	normal cardiovascular system phenotype	J:137067
	centrally nucleated skeletal muscle fibers	J:137067
	decreased skeletal muscle fiber number	J:137067
	decreased skeletal muscle mass	J:137067
	decreased survivor rate	J:137067
	impaired exercise endurance	J:137067
	increased skeletal muscle fiber size	J:137067
	normal muscle phenotype	J:137067
	skeletal muscle fiber atrophy	J:137067
	skeletal muscle fiber necrosis	J:137067
Plectm2Gwi/Plectm2Gwi involves: 129S1/Sv * 129X1/SvJ	abnormal dermal layer morphology	J:59000
	abnormal epidermis stratum basale morphology	J:59000
	abnormal intercalated disk morphology	J:59000
	abnormal keratinocyte morphology	J:59000
	abnormal myocardial fiber morphology	J:59000
	abnormal skeletal muscle fiber morphology	J:59000
	absent epidermis stratum basale	J:59000
	blistering	J:59000
	decreased body weight	J:59000
	hemorrhage	J:59000
	muscle degeneration	J:59000
	myopathy	J:59000
	postnatal lethality, complete penetrance	J:59000
	skin detachment	J:59000
Plectm2Gwi/Plectm4Gwi Tg(Krt1-5-cre/ERT)1Ipc/? involves: 129 * C57BL/6 * SJL	abnormal skin condition	J:124213
	blistering	J:124213
	impaired skin barrier function	J:124213
Plectm3Gwi/Plectm3Gwi involves: 129P2/OlaHsd	abnormal cell morphology	J:104701
	abnormal T cell physiology	J:104701
	abnormal wound healing	J:104701
	decreased fibroblast cell migration	J:104701
	decreased fibroblast chemotaxis	J:104701
	impaired macrophage chemotaxis	J:104701
	impaired wound healing	J:104701
	normal integument phenotype	J:104701
	normal muscle phenotype	J:137067
Plectm4Gwi/Plectm4.1Gwi Tg(Nes-cre)1Kln/0 involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * SJL	decreased nerve conduction velocity	J:155511
Plectm4Gwi/Plectm4Gwi involves: 129P2/OlaHsd * C57BL/6	no abnormal phenotype detected	J:124213
Plectm4Gwi/Plectm4Gwi Tg(Ckmm-cre)5Khn/? involves: 129P2/OlaHsd * C57BL/6J * FVB	abnormal heart morphology	J:137067
	abnormal muscle fiber mitochondrial morphology	J:137067
	abnormal myocardial fiber morphology	J:137067
	abnormal sarcolemma morphology	J:137067
	abnormal skeletal muscle fiber morphology	J:137067
	abnormal soleus morphology	J:137067
	normal cardiovascular system phenotype	J:137067
	centrally nucleated skeletal muscle fibers	J:137067
	decreased skeletal muscle fiber number	J:137067
	decreased skeletal muscle mass	J:137067
	decreased survivor rate	J:137067
	impaired exercise endurance	J:137067
	increased skeletal muscle fiber size	J:137067
	normal muscle phenotype	J:137067
	skeletal muscle fiber atrophy	J:137067
	skeletal muscle fiber necrosis	J:137067
Plectm4Gwi/Plectm4Gwi Tg(KRT5-cre)1Tak/? involves: 129P2/OlaHsd * C3H * C57BL/6	abnormal skin condition	J:124213
	abnormal suckling behavior	J:124213
	blistering	J:124213
	decreased body size	J:124213
	impaired skin barrier function	J:124213
	postnatal growth retardation	J:124213
	postnatal lethality, complete penetrance	J:124213
	skin lesions	J:124213
Plectm5Gwi/Plectm5Gwi involves: 129P2/OlaHsd * C57BL/6	abnormal aerobic respiration	J:137067
	abnormal skeletal muscle fiber morphology	J:137067
	centrally nucleated skeletal muscle fibers	J:137067
	decreased skeletal muscle fiber diameter	J:137067
	increased skeletal muscle fiber size	J:137067
	skeletal muscle fiber necrosis	J:137067
Plectm6Gwi/Plectm6Gwi Not Specified	normal muscle phenotype	J:137067
Plectm7.1Gwi/Plec+ involves: 129P2/OlaHsd * C57BL/6	abnormal keratinocyte morphology	J:179812
	abnormal keratinocyte physiology	J:179812
	abnormal skin exfoliation	J:179812
	dermal-epidermal separation	J:179812
	skin lesions	J:179812
Plectm7.1Gwi/Plectm7.1Gwi involves: 129P2/OlaHsd * C57BL/6	abnormal keratinocyte morphology	J:179812
	abnormal skin exfoliation	J:179812
	dermal-epidermal separation	J:179812
	skin lesions	J:179812